- Home
- DOW vs MEDP Comparison
DOW vs MEDP Comparison
Compare DOW & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOW
- MEDP
- Stock Information
- Founded
- DOW 1897
- MEDP 1992
- Country
- DOW United States
- MEDP United States
- Employees
- DOW N/A
- MEDP N/A
- Industry
- DOW Major Chemicals
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DOW Industrials
- MEDP Health Care
- Exchange
- DOW Nasdaq
- MEDP Nasdaq
- Market Cap
- DOW 16.3B
- MEDP 13.4B
- IPO Year
- DOW N/A
- MEDP 2016
- Fundamental
- Price
- DOW $22.97
- MEDP $597.63
- Analyst Decision
- DOW Hold
- MEDP Hold
- Analyst Count
- DOW 15
- MEDP 11
- Target Price
- DOW $27.13
- MEDP $451.70
- AVG Volume (30 Days)
- DOW 13.3M
- MEDP 347.9K
- Earning Date
- DOW 10-23-2025
- MEDP 10-22-2025
- Dividend Yield
- DOW 6.20%
- MEDP N/A
- EPS Growth
- DOW N/A
- MEDP 25.36
- EPS
- DOW N/A
- MEDP 14.32
- Revenue
- DOW $40,913,000,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- DOW N/A
- MEDP $21.48
- Revenue Next Year
- DOW $2.98
- MEDP $11.90
- P/E Ratio
- DOW N/A
- MEDP $41.52
- Revenue Growth
- DOW N/A
- MEDP 13.88
- 52 Week Low
- DOW $20.40
- MEDP $250.05
- 52 Week High
- DOW $49.70
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- DOW 47.32
- MEDP 68.77
- Support Level
- DOW $22.56
- MEDP $572.12
- Resistance Level
- DOW $25.65
- MEDP $595.00
- Average True Range (ATR)
- DOW 0.70
- MEDP 21.08
- MACD
- DOW -0.02
- MEDP 1.12
- Stochastic Oscillator
- DOW 32.43
- MEDP 73.05
About DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.